sometexan84
Senior Member
- Messages
- 1,183
It's been 5 yrs since @Waverunner posted about this - Mayo Clinic: Is Larazotide Acetate the Answer to Leaky Gut/Celiac Disease?
And it's just now nearing completion, undergoing Phase III trials now.
https://www.beyondceliac.org/research/drugdevelopment/drug-development-pipeline/
Larazotide Acetate drastically improves intestinal barrier integrity. It's a zonulin antagonist.
Increased serum zonulin levels are accompanied by a leaky intestinal barrier, dysbiosis and inflammation. Zonulin is a fairly new discovery, and it appears can be used as a biomarker for leaky gut & intestinal permeability testing.
Ref 1. Targeting zonulin and intestinal epithelial barrier function to prevent onset of arthritis
Ref 2. All disease begins in the (leaky) gut: role of zonulin-mediated gut permeability in the pathogenesis of some chronic inflammatory diseases
John Temperato (9 Meters Biopharma) says...
And it's just now nearing completion, undergoing Phase III trials now.
https://www.beyondceliac.org/research/drugdevelopment/drug-development-pipeline/
Larazotide Acetate drastically improves intestinal barrier integrity. It's a zonulin antagonist.
Increased serum zonulin levels are accompanied by a leaky intestinal barrier, dysbiosis and inflammation. Zonulin is a fairly new discovery, and it appears can be used as a biomarker for leaky gut & intestinal permeability testing.
Ref 1. Targeting zonulin and intestinal epithelial barrier function to prevent onset of arthritis
Ref 2. All disease begins in the (leaky) gut: role of zonulin-mediated gut permeability in the pathogenesis of some chronic inflammatory diseases
John Temperato (9 Meters Biopharma) says...
He expects to perform an interim analysis by mid-2021 and a final analysis at the end of that year. “We want to petition the FDA for conditional approval.” The waiver helps support that.